ADMD: Licences Patent for Alpha-Emitting Radionuclide Actinium-225 (Nasdaq)
ADMD: Licences Patent for Alpha-Emitting Radionuclide Actinium-225 (Nasdaq)
Advanced Medical Isotopes Corporation’s (ADMD) Chief Executive Officer, William Stokes, is pleased to announce the licensing of United States Patent 6,680,993. Stokes said, “This patent is involved with the methods and processes directed to the preparation of Actinium-225 and daughters having high radiochemical and radionuclidic purity, which may be used for the preparation of …